Annals of Surgical Oncology

, Volume 15, Issue 1, pp 104–116 | Cite as

Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients

  • Mitsuo Tachibana
  • Noriyuki Hirahara
  • Shoichi Kinugasa
  • Hiroshi Yoshimura
Gastrointestinal Oncology Original Paper



The depth of tumor penetration is a crucial factor in determining the prognosis of patients with esophageal carcinoma. Patients with superficial esophageal carcinoma (SEC) have a far more favorable clinical course compared with those with advanced cancers. The outcome for patients with mucosal cancer is excellent with a 5-year survival rate exceeding 80%. On the other hand, submucosal cancer often metastasizes to regional and/or distant lymph nodes or other organs, and the prognosis of these patients are far from satisfactory.


Among 334 patients with esophageal cancer who underwent surgery between December 1980 and December 2006, 100 patients (30%) had SEC confined to the epithelium, lamina propria mucosa, or submucosa. Patient and tumor characteristics of those 100 patients were studied.


The prevalence of SEC has increased from 13% (8 of 61) in the initial 5-year period (1985–1989) to 44% (41 of 93) in the recent 7-year period (2000–2006). Subjective symptoms were present in 7 (14%) of 51 mucosal cancers and in 13 (27%) of 49 submucosal cancers. The remaining 80 patients (80%) had no subjective symptoms. Ninety-one patients (91%) were diagnosed to have the lesions by endoscopy at the time of screening for gastric problems, and only nine were detected by gastrointestinal series. Four of 51 patients with mucosal cancer had venous or lymph vessel invasion, and among those, only one (2%) had a solitary perigastric lymph node metastasis. In 49 patients with submucosal cancer, 35 (71%) had lymph vessel invasion, 28 (57%) had venous invasion, and 16 (33%) had lymph node metastases. In particular, 15 of 35 patients with positive lymph vessel invasion had lymph node metastasis, whereas only 1 of 14 with negative lymph vessel invasion had lymph node metastasis (P < .05). Among 17 patients with nodal involvement, 4 patients with upper thoracic SEC had upper mediastinum and/or cervical nodal metastases, 11 patients with middle thoracic SEC had widespread upper and lower mediastinal and abdominal metastases, and 2 patients with lower thoracic SEC had lower and abdominal lymph node metastases. Seventy-nine patients were alive without recurrence at last follow-up. Five of 49 patients with submucosal cancer died of recurrent disease, and 4 of these developed regional nodal recurrence around the bilateral laryngeal recurrent nerves. Forty-two patients (42%) developed double cancers during the follow-up period, and 5 died of a second cancer. The 3- and 5-year survival rates of all 100 patients were 85% and 73%, and those disease-specific survival rates were 96% and 93%, respectively. The 3- and 5-year survival rates for patients with mucosal cancer were 89% and 83%, and those for submucosal cancer were 80%, and 64%, respectively.


Esophagectomy with extensive lymphadenectomy should be carried out particularly for upper thoracic submucosal cancer, whereas esophagectomy with moderate lymphadenectomy may be preferred for mucosal cancer. Patients with SEC should be examined for another primary cancer preoperatively and periodically during follow-up.


Superficial esophageal cancer Early esophageal cancer Clinicopathologic feature Long-term result Double cancer 


  1. 1.
    Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in the rates of esophageal adenocarcinoma: an update. JAMA 1993;270:1320PubMedCrossRefGoogle Scholar
  2. 2.
    Heitmiller RF, Sharma RR. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996;112:130–6PubMedCrossRefGoogle Scholar
  3. 3.
    Daly JM, Fray WA, Little AG, et al. Esophageal cancer: results of an American college of surgeons patient care evaluation study. J Am Coll Surg 2000;190:562–73PubMedCrossRefGoogle Scholar
  4. 4.
    Tachibana M, Kinugasa S, Dhar DK, et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 1999;72:88–93PubMedCrossRefGoogle Scholar
  5. 5.
    Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225–32PubMedCrossRefGoogle Scholar
  6. 6.
    Tachibana M, Kinugasa S, Dhar DK, et al. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 1999;134:50–4PubMedCrossRefGoogle Scholar
  7. 7.
    Japanese Society for Esophageal Disease. Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69–78CrossRefGoogle Scholar
  8. 8.
    Tachibana M, Kinugasa S, Shibakita M, et al. Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg 2006;391:304–21PubMedCrossRefGoogle Scholar
  9. 9.
    Endo M, Yoshino K, Takeshita K, Kawano T. Analysis of 1,125 cases of early esophageal carcinoma in Japan. Dis Esophagus 1991;2:71–6Google Scholar
  10. 10.
    Nageya K. Early carcinoma of the esophagus. In: Nageya K, Hanaoka T, Nogami H, (eds). Recent Advances in Diseases of the Esophagus. Tokyo: Springer-Verlag, 1992:374–80Google Scholar
  11. 11.
    Bonavina L for the Group Europeen pour l’Etude des Maladies de l’Oesophage. Early oesophageal cancer: results of a Europen muticentre survey. Br J Surg 1995;82:98–101PubMedCrossRefGoogle Scholar
  12. 12.
    Tachibana M, Yoshimura H, Kinugasa S, Hashimoto N, Dhar DK, Abe S, Monden N, Nagasue N. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am J Surg 1997;174:49–53PubMedCrossRefGoogle Scholar
  13. 13.
    Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98–109PubMedCrossRefGoogle Scholar
  14. 14.
    Sobin LH, Wittekind C International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997Google Scholar
  15. 15.
    Japanese Society for Esophageal Disease. Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69–78CrossRefGoogle Scholar
  16. 16.
    Kinugasa S, Tachibana M, Yoshimura H, et al. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 2001;71:414–8PubMedCrossRefGoogle Scholar
  17. 17.
    Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457–81CrossRefGoogle Scholar
  18. 18.
    Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003;58(6 Suppl):S3–27Google Scholar
  19. 19.
    Adachi Y, Kitamura K, Ikeda Y, et al. How to detect early carcinoma of the esophagus. Hepato-Gastroenterolgy 1993;40:207–11Google Scholar
  20. 20.
    Sugimachi K, Ohno S, Matsuda H, Mori M, Kuwano H. Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus. Ann Surg 1988;208:179–83PubMedCrossRefGoogle Scholar
  21. 21.
    Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV. Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 1996;44:1–7PubMedCrossRefGoogle Scholar
  22. 22.
    Canto MI, Yoshida T, Gossner L. Chromoscopy of intestinal metaplasia in Barrett’s esophagus. Endoscopy 2002;34:330–6PubMedCrossRefGoogle Scholar
  23. 23.
    Tabuchi M, Sueoka N, Fujimori T. Videoendoscopy with vital double dye staining (crystal violet and methylene blue) for detection of a minute focus of early stage adenocarcinoma in Barrett’s esophagus: a case report. Gastrointest Endosc 2001;54:385–8PubMedCrossRefGoogle Scholar
  24. 24.
    Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995:5:537–47PubMedGoogle Scholar
  25. 25.
    Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Nagasue N. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer (review). Arch Surg 2003;138:1383–9PubMedCrossRefGoogle Scholar
  26. 26.
    Griffin SM, Shaw IH, Dresner S. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg 2002;194:285–97PubMedCrossRefGoogle Scholar
  27. 27.
    Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer: comparison between adeno- and squamous cell carcinoma. Cancer 1995;76:178–86PubMedCrossRefGoogle Scholar
  28. 28.
    Law S, Wong J. What is appropriate treatment for carcinoma of the thoracic esophagus? World J Surg 2001;25:189–95PubMedCrossRefGoogle Scholar
  29. 29.
    Tachibana M, Kinugasa S, Yoshimura H, et al. En bloc esophagectomy for esophageal cancer (review). Am J Surg 2004;188:254–60PubMedCrossRefGoogle Scholar
  30. 30.
    Baba M, Natsugoe S, Shimada M, et al. Does hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg 1999;188:231–6PubMedCrossRefGoogle Scholar
  31. 31.
    Endo M, Takeshita K, Yoshida M. How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy 1986;18(Suppl 3):11–8PubMedCrossRefGoogle Scholar
  32. 32.
    Matsubara T, Ueda M, Abe T, Akimori T, Kokubo N, Takahashi T. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic esophagus. Br J Surg 1999;86:669–73PubMedCrossRefGoogle Scholar
  33. 33.
    Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000;13:125–9PubMedCrossRefGoogle Scholar
  34. 34.
    Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000;88:1285–93PubMedCrossRefGoogle Scholar
  35. 35.
    Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122:1077–86PubMedCrossRefGoogle Scholar
  36. 36.
    Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001;25:424–31PubMedCrossRefGoogle Scholar
  37. 37.
    Wang GQ, Jiao GG, Chang FB, et al. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77:1740–4PubMedCrossRefGoogle Scholar
  38. 38.
    Stein HJ, Feith M, Bruecher BLDM, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer; pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566–75PubMedGoogle Scholar
  39. 39.
    Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446:497–504PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • Mitsuo Tachibana
    • 1
  • Noriyuki Hirahara
    • 1
  • Shoichi Kinugasa
    • 1
  • Hiroshi Yoshimura
    • 1
  1. 1.Digestive Surgery, Department of SurgeryFaculty of Medicine, Shimane UniversityIzumoJapan

Personalised recommendations